NCT06560801View on ClinicalTrials.gov

Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation

PHASE4RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 28, 2023

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions
Chronic Kidney Diseases
Interventions
DRUG

Dapagliflozin 10mg Tab

Randomization will take place at visit 1 to either the group receiving standard care and dapagliflozin or standard care only.

Trial Locations (1)

91054

RECRUITING

Clinical Research Center (CRC), Erlangen

All Listed Sponsors
lead

University of Erlangen-Nürnberg Medical School

OTHER